Treatt PLC (GB:TET)
LSE:TET
Top Page
Treatt plc
(LSE:TET)
Select Model
Select Model
Rating:60Neutral
Price Target:
199.00 p
▲(0.10% Upside)
Action:ReiteratedDate:01/23/26
The score is held back primarily by the FY2025 profitability drop and weaker cash-flow trend despite a strong, low-leverage balance sheet. Technicals are neutral-to-soft with the stock below longer-term moving averages, and valuation looks somewhat stretched at ~25x earnings, partially offset by a ~3.9% dividend yield.
Positive Factors
Strong balance sheet
Very low leverage and substantial equity give Treatt durable financial flexibility. This supports capital allocation for working-capital swings, product investment and dividends, and provides a buffer versus cyclical demand or commodity shocks over the next 2–6 months.
Negative Factors
Profitability reset in FY2025
The sharp decline in revenue and halving of net margin signal structural pressure on pricing, mix or costs. Reduced profitability weakens return metrics and could constrain reinvestment or dividend sustainability if margins do not recover over the coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet
Very low leverage and substantial equity give Treatt durable financial flexibility. This supports capital allocation for working-capital swings, product investment and dividends, and provides a buffer versus cyclical demand or commodity shocks over the next 2–6 months.
Read all positive factors
Treatt plc (TET) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£117.36M
Dividend Yield4.08%
Average Volume (3M)863.87K
Price to Earnings (P/E)32.0
Beta (1Y)0.76
Revenue Growth1.12%
EPS Growth-0.70%
CountryUK
Employees379
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)0.05
Shares Outstanding59,489,550
10 Day Avg. Volume910,892
30 Day Avg. Volume863,865
Financial Highlights & Ratios
PEG Ratio-0.49
Price to Book (P/B)1.20
Price to Sales (P/S)1.23
P/FCF Ratio27.33
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£238.33Price Target Upside19.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.14
Revenue Forecast (FY)£136.86M
Treatt plc Business Overview & Revenue Model
Company Description
Treatt plc, together with its subsidiaries, manufactures and supplies various natural extracts and ingredients to the flavor, fragrance, beverage, and consumer product industries in the United Kingdom, Germany, Ireland, the United States, China, a...
How the Company Makes Money
Treatt makes money primarily by selling natural extract and flavor ingredients to business customers (B2B), with revenues recognized from the manufacture and supply of these ingredients for use in customers’ finished products. Key revenue streams ...
Treatt plc Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
84
Very Positive
Cash Flow
55
Neutral
| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 132.47M | 153.07M | 147.40M | 140.19M | 124.33M |
| Gross Profit | 33.80M | 44.49M | 44.82M | 39.08M | 42.22M |
| EBITDA | 13.15M | 24.22M | 19.31M | 19.05M | 21.52M |
| Net Income | 5.06M | 14.40M | 10.94M | 13.31M | 15.15M |
Balance Sheet | |||||
| Total Assets | 168.59M | 169.85M | 175.02M | 188.18M | 149.42M |
| Cash, Cash Equivalents and Short-Term Investments | 1.75M | 1.79M | 809.00K | 2.35M | 7.26M |
| Total Debt | 8.37M | 2.52M | 11.19M | 24.77M | 16.37M |
| Total Liabilities | 33.85M | 27.84M | 37.77M | 54.33M | 43.12M |
| Stockholders Equity | 134.74M | 142.01M | 137.25M | 133.85M | 106.30M |
Cash Flow | |||||
| Free Cash Flow | 5.94M | 15.40M | 15.78M | -14.16M | -5.80M |
| Operating Cash Flow | 10.67M | 21.07M | 21.49M | -1.39M | 8.57M |
| Investing Cash Flow | -4.97M | -5.63M | -4.16M | -7.17M | -14.36M |
| Financing Cash Flow | -5.67M | -14.37M | -12.51M | 4.38M | 963.00K |
Treatt plc Technical Analysis
Neutral
198.80
Price Trends
202.80
Negative
206.22
Negative
223.13
Negative
Market Momentum
-2.99
Negative
51.02
Neutral
55.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:TET, the sentiment is Neutral. The current price of 198.8 is above the 20-day moving average (MA) of 196.28, below the 50-day MA of 202.80, and below the 200-day MA of 223.13, indicating a neutral trend. The MACD of -2.99 indicates Negative momentum. The RSI at 51.02 is Neutral, neither overbought nor oversold. The STOCH value of 55.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:TET.
Treatt plc Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | £4.02B | 60.70 | 6.17% | 3.45% | 2.36% | -13.99% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | £117.36M | 32.05 | 3.64% | 4.08% | 1.12% | -0.70% | |
58 Neutral | £866.19M | -28.06 | -6.85% | 1.34% | -11.78% | -92.61% | |
51 Neutral | £63.30M | -1.25 | -7.26% | ― | -4.41% | 2.29% | |
49 Neutral | £14.16M | -3.72 | -19.63% | ― | 25.56% | 35.12% | |
46 Neutral | £257.58M | 131.42 | 0.79% | 2.44% | -4.71% | 86.21% |
* Basic Materials Sector Average
GB:TET
Treatt plc
198.80
-111.66
-35.97%
GB:CRDA
Croda International
2,877.00
364.95
14.53%
GB:ELM
Elementis
152.40
40.15
35.76%
GB:ESNT
Essentra
90.60
0.49
0.55%
GB:ITX
Itaconix
105.00
-2.50
-2.33%
GB:SYNT
Synthomer
38.70
-46.10
-54.36%
Treatt plc Corporate Events
Regulatory Filings and Compliance
Treatt Updates Total Voting Rights for Regulatory Disclosure Purposes
Neutral
Feb 19, 2026
Treatt plc has clarified that it has 61,283,093 ordinary shares in issue, but after excluding 1,793,543 treasury shares and 454,418 shares held in employee benefit and SIP trusts—on which voting rights are waived—the total number of vo...
Business Operations and StrategyExecutive/Board Changes
Treatt Confirms Randhawa as Permanent CFO and Adjusts Board Committees
Positive
Feb 12, 2026
Treatt plc, a specialist in natural extracts and ingredients for the beverage, flavour and fragrance markets, has strengthened its leadership team with the permanent appointment of Manprit Randhawa as Group Chief Financial Officer, effective 11 Fe...
Financial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Treatt Publishes 2025 Annual Report and Issues Notice of 2026 AGM
Neutral
Jan 30, 2026
Treatt plc has published its Annual Report and Accounts for the financial year ended 30 September 2025 and has also issued the notice of its 2026 Annual General Meeting, which will be held on 26 March 2026 at Investec plc’s offices in London...
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Treatt Seals Governance Pact With Major Shareholder Döhler and Adds Industry Veteran to Board
Positive
Jan 20, 2026
Treatt has formalised its relationship with major shareholder Döhler Finance Management B.V., which holds about 28% of its share capital, through a customary relationship agreement designed to ensure arm’s-length dealings, adherence to ...
Business Operations and StrategyStock BuybackDividendsFinancial Disclosures
Treatt Profits Slump as Market Headwinds Bite but Group Banks on Global Expansion and Döhler Tie-Up
Negative
Jan 20, 2026
Treatt reported a sharp downturn in full-year performance for the year to 30 September 2025, with revenue falling 11.8% to £132.5m and profit before tax and exceptional items dropping 44.4% to £10.3m amid weak US consumer demand, tariff ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.